A Study on the Effect of Nipocalimab on Vaccine Responses in Healthy Participants
Status:
Recruiting
Trial end date:
2023-09-29
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess the effect of nipocalimab treatment on the antibody (a
protein made in the body to response to a foreign substance) response following tetanus,
diphtheria, pertussis (Tdap) vaccination in healthy participants at Week 4.